Cargando…

Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas

Cyclin D1, a G1-S phase regulator, is upregulated in parathyroid adenomas. Since cyclin-dependent kinase (CDK) inhibitors, CDKN2A and CDKN2B, and RASSF1A (Ras-association domain family 1, isoform A) are involved in G1-S phase arrest and act as potential tumor suppressor genes, we aimed to study pote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arya, Ashutosh Kumar, Bhadada, Sanjay Kumar, Singh, Priyanka, Sachdeva, Naresh, Saikia, Uma Nahar, Dahiya, Divya, Behera, Arunanshu, Bhansali, Anil, Rao, Sudhaker D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466668/ https://www.ncbi.nlm.nih.gov/pubmed/28600574 http://dx.doi.org/10.1038/s41598-017-03143-8

Ejemplares similares

SAT178 EZH2 Upregulation And Lysine 27 Trimethylation at Histone 3 Is Associated With Severe Sporadic Primary Hyperparathyroidism
por: Kumari, Poonam, et al.
Publicado: (2023)

Pediatric Parathyroid Carcinoma: A Case Report and Review of the Literature
por: Dutta, Aditya, et al.
Publicado: (2019)

Frequency & predictors of pancreatitis in symptomatic primary hyperparathyroidism
por: Arya, Ashutosh Kumar, et al.
Publicado: (2018)

Unusual association of primary hyperparathyroidism, papillary thyroid carcinoma, and follicular adenoma in a young female
por: Sridhar, Subbiah, et al.
Publicado: (2013)

IGF-II-secreting pelvic tumor presenting with neuropsychiatric symptoms
por: Dahiya, Divya, et al.
Publicado: (2013)

Effect of gender, biochemical parameters & parathyroid surgery on gastrointestinal manifestations of symptomatic primary hyperparathyroidism
por: Shah, Viral N., et al.
Publicado: (2014)

Role of cytotoxic T cells and PD-1 immune checkpoint pathway in papillary thyroid carcinoma
por: Banerjee, Sohini, et al.
Publicado: (2022)

Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer
por: Tang, Bo, et al.
Publicado: (2015)

CDKN2A gene inactivation in epithelial sporadic ovarian cancer
por: Niederacher, D, et al.
Publicado: (1999)

The hypermethylation of the CDKN2A and CHFR promoter region is a key regulatory mechanism of CDKN2A and CHFR expression in esophageal squamous cell carcinoma
por: Mei, Xinyu, et al.
Publicado: (2019)

The prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis
por: Xing, X, et al.
Publicado: (2013)

Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
por: Juhlin, C. Christofer, et al.
Publicado: (2010)

Effect of curative parathyroidectomy on insulin resistance
por: Putnam, Rachel, et al.
Publicado: (2016)

Diagnostic performance of RASSF1A and CDKN2A gene methylation versus α-fetoprotein in hepatocellular carcinoma
por: Nomeir, Hanan, et al.
Publicado: (2022)

Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1A
por: Waheed, Sana, et al.
Publicado: (2019)

Large parathyroid adenomas: Potential mechanisms to reconcile adenoma size and disease phenotype
por: Bhan, Arti, et al.
Publicado: (2023)

Loss of Both CDKN2A and CDKN2B Allows for Centrosome Overduplication in Melanoma
por: Patel, Shyamal, et al.
Publicado: (2020)

Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B
por: Soto, José Luis, et al.
Publicado: (2005)

SAT180 Comparison Between Sporadic Primary Hyperparathyroidism And Multiple Endocrine Neoplasia Type 1 (MEN1)-Associated Primary Hyperparathyroidism: A Retrospective Analysis Of The Indian PHPT Registry
por: Bhadada, Sanjay, et al.
Publicado: (2023)

Investigation of MLH1, MGMT, CDKN2A, and RASSF1A Gene Methylation in Thymomas From Patients With Myasthenia Gravis
por: Coppedè, Fabio, et al.
Publicado: (2020)

Cell-free methylation of RASSF1 and CDKN2AIP genes in the diagnosis of hepatocellular carcinoma associated with hepatitis B virus cirrhosis
por: Telli, Pelin, et al.
Publicado: (2022)

Loss of CDKN2A and CDKN2B expression is associated with disease recurrence in oral cancer
por: Deepak Roshan, V G, et al.
Publicado: (2019)

Silencing of RASSF3 by DNA Hypermethylation Is Associated with Tumorigenesis in Somatotroph Adenomas
por: Peng, Hu, et al.
Publicado: (2013)

Roles of CDKN1B in cancer?
por: Belletti, Barbara, et al.
Publicado: (2015)

Dual Suppression of the Cyclin-Dependent Kinase Inhibitors CDKN2C and CDKN1A in Human Melanoma
por: Jalili, Ahmad, et al.
Publicado: (2012)

IL-17 A correlates with disease progression in papillary thyroid carcinoma
por: Banerjee, Sohini, et al.
Publicado: (2023)

Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours.
por: Schuyer, M., et al.
Publicado: (1996)

Molecular Genetics and Functional Analysis Implicate CDKN2BAS1-CDKN2B Involvement in POAG Pathogenesis
por: Rathi, Sonika, et al.
Publicado: (2020)

Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism
por: Mazarico-Altisent, I., et al.
Publicado: (2022)

Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients
por: Spitzwieser, Melanie, et al.
Publicado: (2017)

Promoter Methylation of CDKN2A, RARβ, and RASSF1A in Non-Small Cell Lung Carcinoma: Quantitative Evaluation Using Pyrosequencing
por: Lee, Jung Uee, et al.
Publicado: (2012)

Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours.
por: Schmidt, E. E., et al.
Publicado: (1997)

The tumor suppressor CDKN3 controls mitosis
por: Nalepa, Grzegorz, et al.
Publicado: (2013)

The tumor suppressor CDKN3 controls mitosis
por: Nalepa, Grzegorz, et al.
Publicado: (2013)

Association Study of Genetic Variants in CDKN2A/CDKN2B Genes/Loci with Late-Onset Alzheimer's Disease
por: Tedde, Andrea, et al.
Publicado: (2011)

Germline hemizygous deletion of CDKN2A–CDKN2B locus in a patient presenting with Li–Fraumeni syndrome
por: Chan, Sock Hoai, et al.
Publicado: (2016)

CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma
por: Dai, Wei, et al.
Publicado: (2016)

Kras Gene Mutation and RASSF1A, FHIT and MGMT Gene Promoter Hypermethylation: Indicators of Tumor Staging and Metastasis in Adenocarcinomatous Sporadic Colorectal Cancer in Indian Population
por: Sinha, Rupal, et al.
Publicado: (2013)

Pulmonary function tests in patients with primary hyperparathyroidism
por: Bhadada, Sanjay Kumar, et al.
Publicado: (2012)

Tbx2 Controls Lung Growth by Direct Repression of the Cell Cycle Inhibitor Genes Cdkn1a and Cdkn1b
por: Lüdtke, Timo H-W., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_giovkqboidbrt5k95062bfvqte